Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
A groundbreaking new drug, Baxdrostat, has shown remarkable success in clinical trials, offering new hope for millions struggling with treatment-resistant hypertension. This daily pill could revolutionise how high blood pressure is managed across Britain.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
A lethal batch of 'One Dollar' street pills, suspected to contain deadly fentanyl, has claimed two lives in the UK, prompting a major public health warning from authorities.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
British researchers have announced a groundbreaking 'functional cure' for HIV. A new once-a-day pill has shown remarkable success in suppressing the virus, even in patients with drug-resistant strains, potentially eliminating the need for lifelong medicat
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
Tennis legend Serena Williams sparks conversation after sharing her use of GLP-1 medication for weight management, challenging stigma and highlighting the personal nature of health decisions.
Exclusive NHS data reveals a shocking rise in children as young as ten being prescribed anti-obesity injections like Wegovy, raising serious safety concerns among medical experts.
A British woman reveals how she lost over four stone using controversial 'fat jab' injections without changing her diet or exercise routine. Exclusive before-and-after photos and expert medical warnings.
The soaring cost of revolutionary new obesity drugs like Wegovy could force the NHS into a stark choice: ration treatments or find billions in new funding. This investigation reveals the immense financial pressure facing the health service.
Tennis legend Serena Williams and Reddit co-founder Alexis Ohanian endorse GLP-1 medications, advocating for their benefits while calling for reduced stigma and improved accessibility in weight management treatment.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Scotland's NHS is spending a staggering £10 million annually on weight-loss injections like Ozempic and Wegovy as the nation battles a severe obesity epidemic. This investigative report reveals the soaring prescription costs and the pressing health challe
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Exclusive: Pioneering Oxford research reveals hormonal contraceptives physically reshape women's brains, raising urgent questions about long-term neurological impacts and medical practice.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.
Groundbreaking research suggests popular weight loss injections like Wegovy and Ozempic could significantly lower the risk of obesity-related cancers, offering a potential double benefit for millions.
A British mother reveals how the diabetes drug Mounjaro transformed her life, helping her lose over five stone and break a debilitating shopping addiction, saving her thousands of pounds in the process.
Novo Nordisk has announced significant price cuts for its popular weight-loss and diabetes drugs, Ozempic and Wegovy, making them more accessible to patients across the UK.
Discover how to transition from Mounjaro to Wegovy safely and avoid weight regain, as explained by a leading GP. Plus, why the 'King Kong' jab could triple in price.
A recent study suggests that popular weight loss drugs Ozempic and Wegovy, containing semaglutide, may increase the risk of a rare eye condition leading to vision loss. Experts urge caution.
A controversial lawsuit in Texas seeks to restrict access to a widely used abortion pill, sparking nationwide debate on reproductive rights.
A groundbreaking new pill could transform cancer treatment by allowing patients to undergo chemotherapy at home, reducing hospital visits and improving quality of life.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.